Characterization of ligand binding properties of the 5-HT(1D) receptors cloned from chimpanzee, gorilla and rhesus monkey in comparison with those from the human and guinea pig receptors

Neuroscience Letters

Volumn 235, Issue 3, 1997, Pages 117-120

  Pregenzer, Jeffrey F ^a   Alberts, Glen L ^a   Bock, Jeffrey H ^a   Slightom, Jerry L ^a   Bin Im, Wha ^a  

^a PFIZER INC   (United States)

Author keywords

5 HT(1D); Anti migraine drugs; Chimpanzee; Gorilla; Rhesus monkey; Serotonergic ligands

Indexed keywords

SEROTONIN; SEROTONIN RECEPTOR; SUMATRIPTAN;

CHIMPANZEE; GORILLA; GUINEA PIG; LIGAND BINDING; MIGRAINE; MOLECULAR CLONING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RHESUS MONKEY; SEROTONINERGIC NERVE CELL; TRIGEMINUS GANGLION;

EID: 0031576323     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00728-3     Document Type: Article

References (17)

1. Boess F.G., Martin I.L. Molecular biology of 5-HT receptors. Neuropharmacology. 33:1994;275-317.
2. Bouchelet I., Cohen Z., Case B., Séguéla P., Hamel E. Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels. Mol. Pharmacol. 50:1996;219-223.
3. 1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine. Cephalalgia. 11:1991;165-168.
4. Caekebeke J.F.V., Ferrari M.D., Zwetsloot C.P., Jansen J., Saxena P.R. Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attack. Neurology. 42:1992;1522-1526.
5. 1d receptor agonism predicts antimigraine efficacy. Headache. 31:1991;228-231.
6. Friberg L., Olesen J., Iversen H.K., Sperling B. Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Lancet. 338:1991;13-17.
7. 1Dβ receptors. FEBS Lett. 377:1995;73-76.
8. 1-like receptor agonist GR453175. Cephalalgia. 9(Suppl. 9):1989;23-33.
9. Lee W.S., Moskowitz M.A. Conformationally restricted sumatriptan analogues, CP-122,288 and CP-122,638 exhibit enhanced potency against neurogenic inflammation in dura mater. Brain Res. 626:1993;303-305.
10. Libert F., Parmentier M., Lefort A., Dinsart C., Van Sande J., Maenhaut C., Simons M.-J., Dumont J.E., Vassart G. Selective amplification and cloning of four new members of the G protein-coupled receptor family. Science. 244:1989;569-572.
11. 1Dα receptor, Soc. Neurosci. Abstr., 21 (1995) 442.3.
12. Moskowitz M.A. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology. 43(Suppl. 3):1993;S16-S20.
13. A receptors of the α1β2 and α1β2γ2 subtypes. Mol. Pharmacol. 43:1993;801-806.
14. 1Dα serotonin receptor gene expression in trigeminal ganglia: implications for antimigraine drug development. Proc. Natl. Acad. Sci. USA. 91:1994;3666-3669.
15. Schmetterer L., Wolzt M., Krejcy K., Graselli U., Findl O., Eichler H.-G., Singer E.A. Cerebral and ocular hemodynamic effects of sumatriptan in the nitroglycerin headache model. Clin. Pharmacol. Ther. 60:1996;199-205.
16. 1Dβ. Proc. Natl. Acad. Sci. USA. 89:1992;3630-3634.
17. 1D receptor subtypes, Soc. Neurosci. Abstr., 22 (1996) 528.7.